Abstract

We developed a mathematical model to compare 2 indoor remediation strategies in the aftermath of an outdoor release of 1.5 kg of anthrax spores in lower Manhattan. The 2 strategies are the fumigation approach used after the 2001 postal anthrax attack and a HEPA/vaccine plan, which relies on HEPA vacuuming, HEPA air cleaners, and vaccination of reoccupants. The HEPA/vaccine approach leads to few anthrax cases among reoccupants if applied to all but the most heavily contaminated buildings, and recovery is much faster than under the decades-long fumigation plan. Only modest environmental sampling is needed. A surge capacity of 10,000 to 20,000 Hazmat workers is required to perform remediation within 6 to 12 months and to avoid permanent mass relocation. Because of the possibility of a campaign of terrorist attacks, serious consideration should be given to allowing or encouraging voluntary self-service cleaning of lightly contaminated rooms by age-appropriate, vaccinated, partially protected (through masks or hoods) reoccupants or owners.

Highlights

  • Anthrax is a zoonotic disease caused by the spore-forming bacterium Bacillus anthracis (1,2 )

  • Before the mechanisms of humoral and cellular immunity were understood, researchers demonstrated that inoculation of animals with attenuated strains of B. anthracis led to protection (41,42 )

  • In the United States, during 1957–1960, the vaccine was improved through a) the selection of a B. anthracis strain that produced a higher fraction of protective antigen (PA) under microaerophilic conditions, b) the production of a protein-free media, and c) the use of aluminum hydroxide rather than alum as the adjuvant (50,51 )

Read more

Summary

Use of Anthrax Vaccine in the United States

U.S DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Atlanta, GA 30333 The MMWR series of publications is published by the Epidemiology Program Office, Centers for Disease Control and Prevention (CDC), U.S Department of Health and Human Services, Atlanta, GA 30333.

EXECUTIVE SECRETARY
EX OFFICIO MEMBERS
Recommendations of the Advisory Committee on Immunization Practices
INTRODUCTION
Reducing the Risk for Exposure
Protective Immunity
Anthrax Vaccine Adsorbed
Recommended vaccination schedule
Postponement of vaccination
Vaccine Efficacy
Vaccine Safety
Prelicensure Adverse Event Surveillance
Postlicensure Adverse Event Surveillance
Published Studies About Adverse Events
Management of Adverse Events
Reporting of Adverse Events
Vaccination During Lactation
Previous History of Anthrax Infection
Occupational and Laboratory Exposures
Bioterrorism Preparedness
Following Inhalation Exposure
Following Cutaneous or Gastrointestinal Exposure
RESEARCH AGENDA
Penicillin VK
Evaluating Changes in the Current Vaccine Schedule and Route
Human Safety Studies
Postexposure Prophylaxis
Antibiotic Susceptibility and Treatment Studies
Safety of Anthrax Vaccine in Clinical Toxicology Studies Among Pregnant Animals
Continuing Education Activity Sponsored by CDC
By Mail or Fax
Centers for Disease Control and Prevention
GOAL AND OBJECTIVES
Fax Number
Findings
Date I Completed Exam
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.